Sensor Imovax +Fin is promoted as a trading resource, but its public page repeatedly describes connecting readers with financial education providers. It also refers to broker matching. Those are distinct services, and the page does not give us an authenticated customer journey linking them.
A cited page is a source of claims, not independent verification.
What we observed
The Sensor Imovax +Fin website, captured on 21 September 2026, contains contact forms, education language and statements that a representative will call. A headline refers to $2,000 in market opportunities. We do not interpret that as a deposit requirement, cash bonus or amount a customer can earn.
The page publishes learner and engagement figures, but we have not authenticated their measurement or underlying records. We also did not submit an enquiry, speak to a representative or verify a particular education supplier.
What would the customer receive?
Before entering personal information, clarify whether the next step is a course introduction, a broker contact or access to software. Ask for the name of the recipient and the purpose for which the details will be used. A provider introduced later should have its own identifiable contract and costs; the initial page does not validate that later offer.
Our conclusion
The evidence supports describing a promotional contact and introduction page. It does not support calling Sensor Imovax +Fin a tested trading platform or an authenticated broker. We have no verified course outcome, account fee, custody arrangement or withdrawal experience. Status remains unknown, with the service's exact role and the accountable company still needing to be established.